• No results found

VzorekAnalyt9.5.201118.5.20111.6.201115.6.201129.6.2011TOmethan (µg/l)0.285ethan (µg/l)<0.25ethylen (µg/l)<0.25vodík (µg/l)<10H

N/A
N/A
Protected

Academic year: 2022

Share "VzorekAnalyt9.5.201118.5.20111.6.201115.6.201129.6.2011TOmethan (µg/l)0.285ethan (µg/l)<0.25ethylen (µg/l)<0.25vodík (µg/l)<10H"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Vzorek Analyt

9.5.2011 18.5.2011 1.6.2011 15.6.2011 29.6.2011

TO methan (µg/l) 0.285

ethan (µg/l) <0.25

ethylen (µg/l) <0.25

vodík (µg/l) <10

H2S (µg/l) <0.003

psychrofilní bakt. (KTJ/ml) 3.80E+04 anaer. a fak. anaer. bakt. (KTJ/ml) 4.00E+01 síran red. bak. (KTJ/ml) 0.00E+00

K/N/kontrola (bez substrátu) methan (µg/l) 0.389 0.000 0.348 0.359

ethan (µg/l) <0.25 <0.25 <0.25 <0.21

ethylen (µg/l) <0.25 <0.25 <0.25 <0.19

vodík (µg/l) <10 <10 <10 <14

H2S (µg/l) <0.003 0.018 <0.003 <0.003

psychrofilní bakt. (KTJ/ml) 8.40E+03 6.00E+04 1.90E+05 4.20E+03 anaer. a fak. anaer. bakt. (KTJ/ml) 6.00E+01 0.00E+00 0.00E+00 0.00E+00

síran red. bak. (KTJ/ml) 0.00E+00 0.00E+00 0.00E+00 0.00E+00

K/N/SYR (syrovátka) methan (µg/l) 0.395 0.836 0.612

ethan (µg/l) <0.25 0.153 <0.25

ethylen (µg/l) <0.25 0.249 <0.25

vodík (µg/l) 239.19 <10 <10

H2S (µg/l) <0.003 16.776 0.048 0.059

psychrofilní bakt. (KTJ/ml) 6.40E+04 1.90E+05 2.30E+06 1.60E+04 anaer. a fak. anaer. bakt. (KTJ/ml) 8.00E+01 2.20E+03 0.00E+00 0.00E+00

síran red. bak. (KTJ/ml) 0.00E+00 0.00E+00 0.00E+00 5.00E+01

K/S/SYR (syrovátka sterilní) methan (µg/l) 0.283 0.254 0.508 0.402

ethan (µg/l) <0.25 <0.25 <0.25 <0.15

ethylen (µg/l) <0.25 <0.25 <0.25 0.121

vodík (µg/l) <10 <10 <10 14.5

H2S (µg/l) 0.017 <0.003 <0.003 <250

psychrofilní bakt. (KTJ/ml) 3.90E+04 1.40E+06 1.40E+07 2.40E+05 anaer. a fak. anaer. bakt. (KTJ/ml) 4.80E+03 0.00E+00 8.20E+04 0.00E+00

síran red. bak. (KTJ/ml) 0.00E+00 0.00E+00 0.00E+00 0.00E+00

K/N/OL (rostl. olej) methan (µg/l) 0.252 0.237 0.284

ethan (µg/l) <0.25 <0.25 <0.25

ethylen (µg/l) <0.25 <0.25 <0.25

vodík (µg/l) <10 <10 <10

H2S (µg/l) <0.003 <0.003 <0.003 <0.003

psychrofilní bakt. (KTJ/ml) 2.20E+04 1.80E+02 1.70E+04 3.20E+03 anaer. a fak. anaer. bakt. (KTJ/ml) 0.00E+00 1.20E+02 1.00E+02 3.40E+02

síran red. bak. (KTJ/ml) 0.00E+00 0.00E+00 0.00E+00 0.00E+00

K/S/OL (rostl. olej sterilní) methan (µg/l) 0.286 0.230 0.267 0.232

ethan (µg/l) <0.25 <0.25 <0.25 0.105

ethylen (µg/l) <0.25 <0.25 <0.25 0.178

vodík (µg/l) <10 <10 <10 <11

H2S (µg/l) <0.003 0.011 <0.003 <250

psychrofilní bakt. (KTJ/ml) 8.00E+01 4.00E+01 1.00E+03 8.00E+02 anaer. a fak. anaer. bakt. (KTJ/ml) 8.00E+01 0.00E+00 0.00E+00 0.00E+00

síran red. bak. (KTJ/ml) 0.00E+00 0.00E+00 0.00E+00 0.00E+00

K/N/LAK (laktát) methan (µg/l) 0.389 0.344 0.463 0.445

ethan (µg/l) <0.25 <0.25 <0.25 <0.2

ethylen (µg/l) <0.25 0.11 0.11 0.128

vodík (µg/l) <10 <10 <10 <13.5

H2S (µg/l) <0.003 0.123 0.022 <250

psychrofilní bakt. (KTJ/ml) 5.80E+04 1.90E+06 4.80E+06 1.50E+06 anaer. a fak. anaer. bakt. (KTJ/ml) 8.00E+01 1.40E+02 7.00E+01 5.00E+01

síran red. bak. (KTJ/ml) 0.00E+00 0.00E+00 0.00E+00 0.00E+00

K/S/LAK (laktát sterilní) methan (µg/l) 0.348 0.221 0.262

ethan (µg/l) <0.25 <0.25 <0.25

ethylen (µg/l) <0.25 <0.25 <0.25

vodík (µg/l) <10 <10 <10

H2S (µg/l) <0.003 <0.003 <0.003 <0.003

psychrofilní bakt. (KTJ/ml) 2.60E+04 2.20E+03 1.20E+04 1.60E+03 anaer. a fak. anaer. bakt. (KTJ/ml) 1.80E+02 0.00E+00 0.00E+00 0.00E+00

síran red. bak. (KTJ/ml) 0.00E+00 0.00E+00 0.00E+00 0.00E+00

Datum odběru

References

Related documents

With a focus on speed, safety and high performance, the company deve- loped the Nano Induced Magnetic Transfer (NIMT™) technology, which is both a method and a technical tool

ICA is planning to maintain a high establishment rate in 2007 with a large number of new stores on the way at the same time as development and renewal are under way in the

ACquiSiTiON OF SPECiAliST DRuG FROM NOvARTiS, FEBRuARy 2006 Meda acquired the European rights to Parlodel, a proven dopamine agonist-prolactin inhibitor. Meda plans to use target

We recommend to the Annual General Meeting of shareholders that the income statements and balance sheets of the Parent Company and the Group be adopted, that the profit of the

0 shares. Business Unit Manager Invita since 1974. Employed by Invita since 1974. Business Unit Manager Hygena, included in Nobia since February 2006. Business Unit Manager HTH

The consolidated fi nancial statements of Nordnet AB (the parent company) for the fi nancial year ending December 31, 2006 were approved for publication by the Board and Chief

The shares of SKF Sverige AB were sold to another company within the Group. The profit on this transaction amounted to SEK 4,637 million and is included in Financial income. See

We recommend to the General Meeting of Shareholders that the income statements and bal- ance sheets of the parent Company and the Group be adopted, that the profit of the parent